[go: up one dir, main page]

ITMI20001667A0 - DERIVATIVES OF 2- OR 3-TENOIC ACID WITH GLUTAMATE RECEPTOR ANTAGONIST ACTIVITY. - Google Patents

DERIVATIVES OF 2- OR 3-TENOIC ACID WITH GLUTAMATE RECEPTOR ANTAGONIST ACTIVITY.

Info

Publication number
ITMI20001667A0
ITMI20001667A0 IT2000MI001667A ITMI20001667A ITMI20001667A0 IT MI20001667 A0 ITMI20001667 A0 IT MI20001667A0 IT 2000MI001667 A IT2000MI001667 A IT 2000MI001667A IT MI20001667 A ITMI20001667 A IT MI20001667A IT MI20001667 A0 ITMI20001667 A0 IT MI20001667A0
Authority
IT
Italy
Prior art keywords
derivatives
receptor antagonist
antagonist activity
glutamate receptor
tenoic acid
Prior art date
Application number
IT2000MI001667A
Other languages
Italian (it)
Inventor
Roberto Pellicciari
Flavio Moroni
Cristian Noe
Original Assignee
Roberto Pellicciari
Flavio Moroni
Noe Christian
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roberto Pellicciari, Flavio Moroni, Noe Christian filed Critical Roberto Pellicciari
Priority to IT2000MI001667A priority Critical patent/IT1318636B1/en
Publication of ITMI20001667A0 publication Critical patent/ITMI20001667A0/en
Priority to PCT/IB2001/001295 priority patent/WO2002008220A1/en
Priority to AU2001275767A priority patent/AU2001275767A1/en
Publication of ITMI20001667A1 publication Critical patent/ITMI20001667A1/en
Application granted granted Critical
Publication of IT1318636B1 publication Critical patent/IT1318636B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT2000MI001667A 2000-07-21 2000-07-21 2- OR 3- TENOIC ACID DERIVATIVES FOR ANTAGONIST ACTIVITY OF GLUTAMATE RECEPTORS. IT1318636B1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IT2000MI001667A IT1318636B1 (en) 2000-07-21 2000-07-21 2- OR 3- TENOIC ACID DERIVATIVES FOR ANTAGONIST ACTIVITY OF GLUTAMATE RECEPTORS.
PCT/IB2001/001295 WO2002008220A1 (en) 2000-07-21 2001-07-20 2-thenoic acid (thiophene) derivatives having glutamate receptor antagonistic activity
AU2001275767A AU2001275767A1 (en) 2000-07-21 2001-07-20 2-thenoic acid (thiophene) derivatives having glutamate receptor antagonistic activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2000MI001667A IT1318636B1 (en) 2000-07-21 2000-07-21 2- OR 3- TENOIC ACID DERIVATIVES FOR ANTAGONIST ACTIVITY OF GLUTAMATE RECEPTORS.

Publications (3)

Publication Number Publication Date
ITMI20001667A0 true ITMI20001667A0 (en) 2000-07-21
ITMI20001667A1 ITMI20001667A1 (en) 2002-01-21
IT1318636B1 IT1318636B1 (en) 2003-08-27

Family

ID=11445531

Family Applications (1)

Application Number Title Priority Date Filing Date
IT2000MI001667A IT1318636B1 (en) 2000-07-21 2000-07-21 2- OR 3- TENOIC ACID DERIVATIVES FOR ANTAGONIST ACTIVITY OF GLUTAMATE RECEPTORS.

Country Status (3)

Country Link
AU (1) AU2001275767A1 (en)
IT (1) IT1318636B1 (en)
WO (1) WO2002008220A1 (en)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK124393D0 (en) * 1993-11-03 1993-11-03 Lundbeck & Co As H COMPOUNDS
US5962521A (en) * 1997-04-04 1999-10-05 Guilford Pharmaceuticals Inc. Hydroxamic acid derivatives
UA54403C2 (en) * 1996-10-01 2003-03-17 Н'Юросерч А/С indole-2,3-dione-3-oxime derivatives, A PHARMACEUTICAL COMPOSITION, A METHOD FOR TREATING DISORDER OR DISEASE OF MAMMALS INCLUDING A MAN, AND A METHOD FOR PREPARATION OF Indole-2,3-dione-3-oxime derivatives
GB9626151D0 (en) * 1996-12-17 1997-02-05 Lilly Industries Ltd Pharmaceutical compounds
AU5233699A (en) * 1998-07-31 2000-02-21 Eli Lilly And Company Sulfonamide derivatives
PE20000942A1 (en) * 1998-07-31 2000-09-28 Lilly Co Eli DERIVATIVES OF AMIDE, CARBAMATE AND UREA
TW593241B (en) * 1999-04-20 2004-06-21 Hoffmann La Roche Carbamic acid derivatives

Also Published As

Publication number Publication date
ITMI20001667A1 (en) 2002-01-21
AU2001275767A1 (en) 2002-02-05
WO2002008220A1 (en) 2002-01-31
IT1318636B1 (en) 2003-08-27

Similar Documents

Publication Publication Date Title
EE200200439A (en) Use of Central Cannabinoid Receptor Antagonist for the Production of Pharmaceutical Products to Help Quit Tobacco Use
PT1349839E (en) PHENYLETENYL OR PHENYLETINYL DERIVATIVES AS ANTAGONISTS OF THE GLUTAMATE RECEPTOR
ITPD20000207A0 (en) NEW CROSS-LINKED DERIVATIVES OF HYALURONIC ACID.
DK1175401T3 (en) Piperazine derivatives useful as CCR5 antagonists
ITMI20030025A1 (en) HYDROXAMIC ACID DERIVATIVES FOR ANTI-INFLAMMATORY ACTIVITY.
DK1438298T3 (en) Piperazine derivatives with CCR1 receptor antagonist activity
PT1224174E (en) BENZODIAZEPIN DERIVATIVES AS ANTAGONISTS OF THE METHOTROPIC GLUTAMATE RECEPTOR
HUP0202757A3 (en) Heteropolycyclic compounds, pharmaceutical compositions containing them and their use as metabotropic glutamate receptor antagonists
ECSP055531A (en) "NEW DERIVATIVES OF THIOPHEN GLYCOSIDE, METHODS FOR THE PREPARATION OF THE SAME, DRUGS THAT INCLUDE SUCH COMPOUNDS, AND THEIR USE"
HUP0203677A2 (en) Urea compounds having muscarinic receptor antagonist activity
EE200300244A (en) 3-aroylindole derivatives and their use as CB2 receptor agonists
MA26929A1 (en) N-OXIDES AS AN ANTAGONIST NK1 RECEPTOR PROMOTERS OF 4-PHENYL-PYRIDINE DERIVATIVES
BRPI0414539A (en) compound, pharmaceutical composition, and use of a compound
BR9911575A (en) 4-benzyl piperidine alkyl sulfoxide heterocyclics and their use as selective subtype nmda receptor antagonists
EA200100678A1 (en) N-UREIDOALKYL-PIPERIDINES AS MODELS OF ACTIVITY OF RECEPTORS OF CHEMOKINES
NO20032773D0 (en) Pharmaceutical preparation comprising pyrsazolo [4,3-d] pyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives
DK1157005T3 (en) 3-phenylpyridine derivatives and their use as NK-1 receptor antagonists
DE60203797D1 (en) BENZO [D] AZEPINE DERIVATIVES THAN 5-HT6 RECEPTOR ANTAGONISTS
MA26933A1 (en) 4-PHENYL-PYRIDINE DERIVATIVES AS NEUROKININ RECEPTOR ANTAGONISTS 1.
TR200103108T2 (en) Bradykinin receptor antagonists
PT1176144E (en) NEW N-TRIAZOLYLMETHYL PIPERAZINE DERIVATIVES AS NEUROCHININE RECEPTOR ANTAGONISTS
PT1171419E (en) BIPHENYL DERIVATIVES AS ANTAGONISTS OF THE NEUROCHININ-1 RECEPTOR
IL135347A0 (en) New carboxylic acid derivatives, carrying amido side-chains; production and use as endothelin receptor antagonists
DE60015187D1 (en) UROTENSIN-II RECEPTOR ANTAGONISTS
ITMI20001667A0 (en) DERIVATIVES OF 2- OR 3-TENOIC ACID WITH GLUTAMATE RECEPTOR ANTAGONIST ACTIVITY.